Skip to main content
S&P 5007,703.68+1.78%DOW53,353.36+3.03%NASDAQ25,840.70+1.85%BTC$80,191.00+3.38%ETH$2,421.42+5.73%GOLD$4,071.80+3.33%OIL$87.76-8.67%
Smart Investors Daily
SID Premium
LF

NASDAQ · LFMD

LifeMD, Inc.

Healthcare · Medical - Pharmaceuticals

$2.18

Up+$0.29 (+13.07%)

Updated Nov 4, 2026, 5:59 PM

SID Score

3.9/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
166.99M
P/E ratio
-34.8
Dividend yield
0.00%
52-week range
$2.06 – $5.38
Volume
603.37K
Avg. volume
1.2M

Price performance · LFMD

LFMD price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 3, 2026

LFMD closed at $2.18 after 21 trading sessions, down 20.15% for the selected period.

Last close
$2.18
Period change
-20.15%
Period low
$2.08
Period high
$2.79
Daily close
View OHLC price history
LFMD OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 3, 2026$2.30$2.37$2.18$2.18603.37K
Nov 2, 2026$2.33$2.355$2.235$2.31635.89K
Oct 30, 2026$2.30$2.351$2.24$2.29599.13K
Oct 29, 2026$2.24$2.40$2.205$2.32739.73K
Oct 28, 2026$2.13$2.24$2.10$2.23694.44K
Oct 27, 2026$2.08$2.165$2.075$2.12997.07K
Oct 26, 2026$2.13$2.15$2.06$2.08361.13K
Oct 23, 2026$2.17$2.17$2.105$2.13402.08K
Oct 22, 2026$2.13$2.20$2.10$2.17674.29K
Oct 21, 2026$2.28$2.28$2.125$2.14628.31K
Oct 20, 2026$2.27$2.355$2.21$2.245699.73K
Oct 19, 2026$2.35$2.39$2.225$2.25784.41K
Oct 16, 2026$2.44$2.48$2.34$2.34898.47K
Oct 15, 2026$2.36$2.495$2.342$2.46737.27K
Oct 14, 2026$2.47$2.48$2.355$2.37671.81K
Oct 13, 2026$2.55$2.57$2.46$2.47733.39K
Oct 12, 2026$2.65$2.65$2.53$2.55626.43K
Oct 9, 2026$2.66$2.675$2.58$2.63620.37K
Oct 8, 2026$2.77$2.77$2.62$2.65931.45K
Oct 7, 2026$2.70$2.855$2.6804$2.79509.79K
Oct 6, 2026$2.75$2.81$2.71$2.73444.53K

Latest LFMD news

The latest Smart Investors Daily articles mentioning LFMD.

Stock researchCompany · Overview

LFMD research

Overview

Company profile and research snapshot.

Company profile

LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$10.00
Implied upside
—
Analysts
14
LFMD recent ratings
DateFirmRatingTarget
Sep 17, 2026HC Wainwright & Co.Buy—
Aug 7, 2026HC Wainwright & Co.Buy—
Aug 6, 2026B. Riley SecuritiesBuy—
Aug 6, 2026BTIGBuy—
May 26, 2026HC Wainwright & Co.Buy—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 20, 2026

LifeMD to Report Third Quarter 2026 Financial Results on November 9

NEW YORK, Oct. 20, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, announces that it will report financial results for the three and nine months ended September 30, 2026, before the open of the U.S. financial markets on November 9, 2026, and will host a conference call beginning at 8:30 a.m. Eastern time. Conference Call & Webcast Details Date:Monday, November 9thTime:8:30 a.m. Eastern timeToll-Free Dial-In:(877) 270-2148Int

Yahoo · Sep 22, 2026

LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today announced that its Board of Directors has authorized a cash dividend to holders of the Company’s 8.875% Series A Cumulative Perpetual Preferred Stock (Nasdaq: LFMDP) equal to $0.5546875 per share. The preferred dividend will be paid on October 15, 2026, to holders of record at the close of business on October 2, 2026. About LifeMD, Inc. LifeMD® is a le

Yahoo · Sep 20, 2026

LifeMD (LFMD) Secures AT&T Partnership. Can Free Memberships Produce Paying Patients?

LifeMD, Inc. (NASDAQ:LFMD) announced an exclusive healthcare collaboration on September 15 that initially makes virtual-health membership benefits available to approximately 29 million eligible AT&T wireless and fiber customers across 11 states. Customers must be 18 or older, and some services have additional eligibility and state restrictions. A nationwide expansion planned for January 2027 would extend […]

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By